source
- Lundbeck advances PACAP-targeting migraine drug after mid-stage trial shows reduction in migraine daysLundbeck reported new data from a mid-stage study of its experimental migraine prevention therapy, bocunebart, which targets the PACAP protein involved in headache pathways. The trial enrolled hun…
- CDC warns Ebola could swell to 20,000 cases in Central Africa without rapid containmentThe U.S. Centers for Disease Control and Prevention released a new analysis indicating that the Ebola outbreak in Central Africa could expand to as many as 20,000 cases if infected individuals are…